Stay updated on Lintuzumab-Ac225 in Older AML Patients Clinical Trial
Sign up to get notified when there's something new on the Lintuzumab-Ac225 in Older AML Patients Clinical Trial page.

Latest updates to the Lintuzumab-Ac225 in Older AML Patients Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page now displays a 'No longer looking for participants' status, signaling that recruitment has closed. New navigational/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study), the Intervention/Treatment label was updated, and older revision text (Revision: v3.5.5) was removed in favor of Revision: v3.6.0.SummaryDifference0.4%

- Check15 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, indicating a backend or UI patch. No study data or public-facing content changes are reflected in this edit.SummaryDifference0.0%

- Check36 days agoChange DetectedThe page now displays revision v3.5.4 and the previous revision v3.5.3 has been removed.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page’s displayed revision/version number was updated from v3.5.2 to v3.5.3, indicating a site/version release rather than a modification to the underlying study information.SummaryDifference0.0%

- Check65 days agoChange DetectedRevision label on the page updated from v3.5.0 to v3.5.2, reflecting a minor site update rather than changes to study content.SummaryDifference0.0%

- Check93 days agoChange DetectedRevision: v3.5.0 has been added and v3.4.3 has been removed. This update does not modify the study details or page content.SummaryDifference0.0%

Stay in the know with updates to Lintuzumab-Ac225 in Older AML Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lintuzumab-Ac225 in Older AML Patients Clinical Trial page.